Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

9342-8530 Quebec Inc DGCRF

Diagnocure Inc is a Canada based biotechnology company. It is primarily engaged in the business activity of development and commercialization of products relating to the diagnosis of cancer. The group generates its revenue from research and license agreement. The head office of the company is located in Quebec, Canada.


GREY:DGCRF - Post by User

Bullboard Posts
Post by ready2go1on Aug 29, 2011 5:59pm
340 Views
Post# 18990998

Panther

PantherBelieve it or not, my feeling is that they have always said they want this(pca3) to run on Panther, but they have to also get it FDA approved to run on this system.
     They submitted a 510K for Panther in May and will probably hear sometime this upcoming month on approval. I would expect that the new data they submit will not only be to get pca3 FDA approved but to get it approved to run on panther. I am not happy right now, but it ups the game for pca3 and we will now see universal adoption for the test. 
     FDA approval for pca3 would take us to the $3.00 to $4.00 range. FDA approval on panther takes us >$8.00 next year.
(if GPRO is however playing games, they owe us money)
Bullboard Posts